Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
AbbVie
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
navitoclax
(ABT 263) / AbbVie
coltuximab ravtansine
(SAR3419) / AbbVie
Xcytrin
(motexafin gadolinum) / AbbVie
abexinostat
(CG-781) / Xynomic
veliparib
(ABT-888) / AbbVie
